Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 14, Status: Authorised
Agenda of the CAT meeting 4-6 November 2026
Mandate, objectives and rules of procedure for the Scientific Advisory Groups (SAGs) and ad-hoc experts groups (AHEGs)
Agenda - HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations
Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Authorised
Plasma master file certificates
Veterinary medicines European public assessment report (EPAR): Eravac, rabbit haemorrhagic disease vaccine (inactivated), Status: Withdrawn
Agenda - Stakeholder meeting, November 2026
Portfolio and technology meetings